Glytec diabetes software integrates with Onduo Virtual Clinic
WALTHAM, Mass. – Glytec’s digital diabetes management software, Glucommander Outpatient, will be integrated with Onduo’s virtual diabetes clinic now in development. The integrated solution will launch in pilot programs with select U.S. providers and payers early next year. Onduo, a joint venture of Sanofi and the Alphabet company Verily, is developing the virtual platform that integrates hardware, such as wirelessly-connected continuous glucose monitors, software and personalized support from healthcare experts to help people manage their Type 2 diabetes. “Roughly half of 7.5 million people in the U.S. who use insulin to manage their diabetes are not reaching their treatment goals, and millions more who could benefit from insulin therapy either avoid it or discontinue it,” said Dr. Andrew Rhinehart, chief medical officer at Glytec, in a statement. “Fixing this decades-old problem represents one of the greatest opportunities to improve the quality and cost of diabetes care.” According to multiple studies involving the use of Glucommander Outpatient in clinical practice, patients reach their glucose targets in an average of 12.5 days and sustain drops in A1C of 2.5 percentage points over a 12-month period, with very low incidence of hypoglycemia.
Teladoc announces more than 100% growth
PURCHASE, N.Y. – Teladoc has announced growth of more than 100%, now supporting more than 200 hospitals. “Hospitals and health systems are under tremendous operating pressures, particularly as the industry shifts more toward value-based care and they seek to meet the care needs of new populations,” said Dr. Alan Roga, president, health system market, Teladoc, in a statement. “A significant strength and advantage of the Teladoc solution is that it is tailored specifically to support health systems as they expand and innovate their approach to care delivery.” Among the organizations that have selected Teladoc this year are Mount Sinai, New York; Jefferson Health, Philadelphia; Mercy Health Network, Des Moines, Iowa; Parkview Health, Fort Wayne, Ind.; Wellspan Health, York, Pa.; and Orlando Health, Orlando.
Health Wizz launches blockchain-powered health data platform
WASHINGTON – Health Wizz has launched a blockchain-powered technology solution to help give consumers control over their medical data. The Health Wizz secure, decentralized mobile platform enables people to aggregate, organize and share personal medical health records securely and efficiently. “We envision a future where consumers own their medical health data and can easily organize and share their records, in a secure fashion, at little to no cost,” said Raj Sharma, CEO of Health Wizz, in a statement. “The launch of the Health Wizz platform is the first step in bringing this vision to reality.”
YouThisMe partners with OpenTeleHealth on iOS-compatible RPM platform
HUDSON, N.Y. – Mobile health technology company YouThisMe is partnering with OpenTeleHealth, a developer of cloud-based remote patient monitoring platforms for hospitals and health care providers, on an iOS-compatible remote patient monitoring platform. The RPM technology automates the reading of a variety of biometric devices so that clinicians can track the vital signs of patients following discharge to their homes or to post-acute care settings. “We are extremely excited about collaborating with YouThisMe and bringing our years of large-scale RPM experience from Denmark to hospitals, health systems and other providers in the U.S. market,” said Henrik Ibsen, CEO of OpenTeleHealth, in a statement. “Between us, we have a unique and powerful system that can help create efficiencies in resources and drive meaningful change in how and where health care is delivered.”
With the iOS client created by YouThisMe, OpenTeleHealth will be able to expand its platform to an entirely new universe of mobile devices. OpenTeleHealth provides a simple, scalable platform in which physicians and nurses access patient data through a web portal, while patients measure their own health data at home using an app on a mobile device, along with a variety of medical measurement devices.
My Diabetes Coach runner up in HITLAB contest
GATINEAU, QUEBEC – Macadamian’s My Diabetes Coach voice-enabled platform was awarded runner up and $15,000 in the 2017 HITLAB World Cup of Voice-Activated Technology in Diabetes presented by Novo Nordisk. “Receiving this award is validation to the enormous potential this solution has to make an impact on youth suffering from Type 2 diabetes,” said Timon LeDain, director of Internet of Things at Macadamian, in a statement. “We knew that leveraging our Hive platform to create My Diabetes Coach would demonstrate how beneficial the use of voice assistants can be in healthcare. We are truly honored to receive this recognition, and it only empowers our resolve to bring this solution to the mainstream.” This year’s HITLAB event focused on Type 2 diabetes, with each of the finalists creating innovative solutions using voice-activated technology to make it easier for diabetics to manage their care. All of the finalists were judged on their solution’s impact, innovation, sustainability and feasibility.
GPT partners with Trapollo for remote patient monitoring integration
HERNDON, Va. – The Global/Georgia Partnership for Telehealth has partnered with Trapollo, a remote patient monitoring integrator. Through this partnership, health care organizations will be able to source remote monitoring technologies and contract RPM program design, consulting services and non-clinical managed services. “Working with both small and large medical systems, GPT understands the importance of providing the pathway for quality care from the doctor to the patient —wherever the patient might be,” said Rena Brewer, CEO of GPT, in a statement. GPT is a nonprofit corporation formed to promote improvements in health care by establishing turn-key telemedicine programs.
Alaskan primary care to prescribe Livongo diabetes platform
MOUNTAIN VIEW, Calif. – Medical Park Family Care, the largest primary care group in Alaska, will prescribe the Livongo for Diabetes mHealth platform to 4,000 people with diabetes receiving care from the practice. “Our patients can’t always be here at the clinic, but with Livongo they can always access the support and tools they need to manage their diabetes,” said Brandon Ousley, CEO of of Medical Park Family Care, in a statement. Providers will recommend the digital platform, which includes remote patient monitoring and coaching, along with diabetes prescriptions, to ensure that people with diabetes receive 24/7 ongoing support and tools to better self-manage diabetes. “From the very beginning of the digital health revolution, we’ve seen digital solutions, providers and payers operating in silos,” said Dr. Jennifer Schneider, chief medical officer of Livingo, in a statement. “Our partnership with Medical Park is an important step in bringing everyone together with the common goal of making people healthier in an effective, scalable, and sustainable business model.”
Velocity Health program to support digital health startups
LONDON – Biopharmaceutical company Merck Sharp & Dohme and the accelerator Wayra UK have kicked off the third Velocity Health program to award up to $90,000 to two digital health startups using artificial intelligence and machine learning to support disease and illness prevention. Velocity Health was set up in 2015 to invest in digital innovation in healthcare to address the challenges outlined in the National Health Service’s Five Year Forward View. Previous programs focused on prevention in health care with an emphasis on diabetes prevention and cancer prevention. “Velocity Health 2018 aims to build on the achievements of the previous two years of Velocity Health and work with start-ups that truly complement the future of healthcare delivery,” said Dr. Junaid Bajwa, director of health care services at MSD, in a statement. “The NHS has made digital excellence the cornerstone of its future model and we must embrace this if we are to have a healthcare system fit for the 21st Century.”
Blue Cross partners with Alphabet’s Onduo on diabetes management pilot
CHICAGO – The Blue Cross Blue Shield Association has partnered with Onduo, a diabetes management company created by Sanofi and Alphabet’s Verily, on a pilot program that will provide eligible members with access to personalized and convenient diabetes care.
The pilot is designed to measure Type 2 diabetes outcomes, including those relating to clinical improvement, cost and member experience.
“Blue Cross and Blue Shield companies have a long history of bringing locally tailored, innovative programs to the communities we serve,” said Jody Voss, vice president of development, innovation and the group purchasing organization for BCBSA, in a statement. “We are pleased to be able to continue this tradition by partnering with Onduo on a new diabetes management program that will help eligible members better manage their Type 2 diabetes.”
The Onduo platform integrates hardware and software to provide people with access to personalized, convenient diabetes care. Participating BCBS members will be matched to the clinically appropriate interventions, including wirelessly-connected continuous glucose monitoring devices, lifestyle support, medication review and a team of Onduo health care experts. In collaboration with local BCBS network doctors, the program aims to provide care and support to members when and where they want it.
The Onduo platform will extend physicians’ support by providing guidance and continuous support to members between doctor visits.
“Onduo’s goal is to increase access to solid, evidence-based interventions in a personalized manner,” said Josh Riff, CEO of Onduo, in a statement. “Managing diabetes is a 24/7 job that we want to make easier for members.”
Pilots will begin in the first quarter of 2018 in Arkansas, Georgia and South Carolina with select BCBS members who are eligible.
mHealth helps self-management of chronic diseases, study finds
NEW YORK – mHealth can encourage patients with chronic diseases to modify their behaviors, according to a recent study.
“Empowering Patients Using Smart Mobile Health Platforms: Evidence from a Randomized Field Experiment,” a study which combined data from a Chinese mHealth firm, as well as the Office of Chronic Disease Management in China, evaluated the potential value of technologies such as mobile health apps and mobile-enabled EHRs, and the importance of mHealth platform design, in achieving better health care outcomes.
“By assisting patients with behavior modification and disease self-management, mHealth platforms have tremendous potential for improving health outcomes and reducing medical costs,” said Anindya Ghose, a co-author of a paper on the study, in a statement. “With this research, companies have an opportunity to better understand patients’ interaction with mHealth technology and design elements that will be most effective for patient adoption and engagement.”
Analyzing almost 10,000 unique responses from diabetes patients over 15 months, the study revealed: Patients who adopt the mHealth platform see more than a 2000% reduction, on average, in glucose levels over time. They also show an average 327% reduction in hospital visits and 799% reduction in medical expenses.
Other findings from the study: Mobility is key to patients’ self-management success; and platform design is critical to achieving better health outcomes.